Ke. Sandman et al., Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicityand antitumor drug potential of platinum complexes, CHEM BIOL, 6(8), 1999, pp. 541-551
Background: The need for new platinum antitumor drugs is underscored by the
usefulness of cisplatin and carboplatin in chemotherapy and the resistance
of many tumors to these compounds. Combinatorial chemistry could aid in th
e search for cisplatin analogs if fast, high-throughput assays were availab
le. Our goal was to develop rapid cell-based assays suitable for high-throu
ghput screening that accurately predict the cytotoxicity of platinum comple
xes. We examined the effects of platinum complexes and other agents on repo
rter-gene expression in cancer cells.
Results: HeLa Tet-On cells with inducible enhanced green fluorescent protei
n (EGFP) were prepared. Cisplatin and other cis-disubstituted platinum comp
lexes inhibited EGFP expression, with a strong positive correlation between
EGFP inhibition and cytotoxicity. By contrast, trans-[Pt(NH3)(2)Cl-2], oth
er trans-platinum complexes, methyl methanesulfonate or heat shock stimulat
ed EGFP expression. Northern and nuclear run-on analyses revealed that the
changes in EGFP expression were at the level of transcription. In another r
eporter-gene assay in Jurkat cells, cisplatin, but not trans [Pt(NH3)(2)Cl-
2] or K-2[PtCl4], inhibited beta-lactamase expression, as measured by hydro
lysis of the fluorescent substrate CCF2.
Conclusions: The EGFP results indicate that cytotoxic stress enhances trans
cription from the inducible promoter, whereas compounds able to form the 1,
2-intrastrand platinum-DNA cross-links repress transcription, Both fluoresc
ence-based reporter-gene assays afford promising new approaches to platinum
anticancer drug discovery.